-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53

Benzinga·07/23/2026 18:03:09
Listen to the news
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $50 to $53.